General
Preferred name
SULTHIAME
Synonyms
sultiame ()
Sultiamo ()
Riker 594 ()
Ospolot ()
RIKER-594 ()
P&D ID
PD004500
CAS
61-56-3
Tags
available
drug
Drug Status
approved
Max Phase
4.0
Drug indication
Anticonvulsant
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Cell lines
0
Organisms
2
Compound Sets
14
Cayman Chemical Bioactives
36271
ChEMBL Approved Drugs
CHEMBL328560
ChEMBL Drugs
CHEMBL328560
Drug Repurposing Hub
DrugBank
DB08329
DrugBank Approved Drugs
DB08329
DrugCentral
2540
DrugCentral Approved Drugs
2540
DrugMAP
DM07653
DrugMatrix
EU-OPENSCREEN Bioactive Compound Library
EOS102397
MedChem Express Bioactive Compound Library
HY-108316
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
External IDs
33
Properties
(calculated by RDKit )
Molecular Weight
290.04
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
2
Ring Count
2
Aromatic Ring Count
1
cLogP
0.26
TPSA
97.54
Fraction CSP3
0.4
Chiral centers
0.0
Largest ring
6.0
QED
0.84
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Member status
virtual
MOA
Carbonic Anhydrase Type II Inhibitors
Carbonic Anhydrase Type IX Inhibitors
Carbonic Anhydrase Type VII Inhibitors
Carbonic Anhydrase Type XII Inhibitors
Carbonic anhydrase inhibitor
Target
CA2
Carbonic Anhydrase
Pathway
Metabolic Enzyme/Protease
Source data